LANSOPRAZOLE
These highlights do not include all the information needed to use LANSOPRAZOLE DELAYED-RELEASE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for LANSOPRAZOLE DELAYED-RELEASE ORALLY DISINTEGRATING TABLETS. LANSOPRAZOLE delayed-release orally disintegrating tablets, for oral useInitial U.S. Approval: 1995
9b3869ad-f2f7-4954-b75c-5c23b8951635
HUMAN PRESCRIPTION DRUG LABEL
Aug 22, 2022
Zydus Pharmaceuticals USA Inc.
DUNS: 156861945
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
LANSOPRAZOLE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (24)
LANSOPRAZOLE
Product Details
FDA regulatory identification and product classification information